Status: Recruiting
Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer
This is a phase II trial studies the effect of chemoimmunotherapy sequential residual tumor irradiation in treating patients with extensive stage small cell lung cancer. Even though small cell lung cancer is initially highly responsive to first-line chemotherapy plus PD-L1 inhibitors, treatment resistance inevitably happens. Residual tumor irradiation my prolong drug resistance, and may help prevent the growth and spread of the tumor cells to other parts of the body.
Participants needed: 70
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Qingdao Central HospitalUpdated: Jul 23, 2024Locations: 3
Eligibility criteria
ad major surgery within 14 days prior to starting study drug or has not recovere...